References

  1. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015 Mar 1;136(5):E359-86. Epub 2014 Oct 9. PubMed | Google Scholar

  2. Lazaar-Ben Gobrane H, Hajjem S, Aounallah-Skhiri H, Achour N, Hsairi M. [Mortality from cancer in Tunisia: calculating years of life lost]. Sante Publique. 2011 Jan-Feb;23(1):31-40. PubMed | Google Scholar

  3. Blanchon F, Grivaux M, Collon T, Zureik M, Barbieux H, Bénichou-Flurin M et al. Epidémiologie du cancer bronchique primitif et prise en charge dans les hôpitaux généraux francais. Rev Mal Respir. 2002;19(6):727-34. PubMed | Google Scholar

  4. Jemal A, Murray T, Ward E, Samuels A, Tiwari RC, Ghafoor A et al. Cancer statistics, 2005. CA Cancer J Clin. 2005; 55(1):10-30. PubMed

  5. Charles S, Lynn T, Richard A. Lung Cancer: Epidemiology, Etiology, and Prevention. Clin Chest Med. 2011;32(4):605-44. PubMed | Google Scholar

  6. Ramalingam S, Pawlish K, Gadgeel S, Demers R, Kalemkerian GP. Lung cancer in young patients: analysis of a surveillance, epidemiology, and end results database. J Clin Oncol. 1998; 16(2):651-7. PubMed | Google Scholar

  7. Natali F, Guigay J, Laamim M, Vaylet F, L'Her P, Genero-Gygax ML et al. Cancer bronchique primitif chez le sujet de 40 ans et moins. Rev Pneumol Clin. 1991;47(2):80-4. PubMed | Google Scholar

  8. Tokuhata GK, Lilienfeld AM. Familial aggregation of lung cancer in humans. J Natl Cancer Inst. 1963;30:289-312. PubMed | Google Scholar

  9. Thomas A, Chen Y, Yu T, Jakopovic M, Giaccone G. Trends and Characteristics of Young Non-Small Cell Lung Cancer Patients in the United States. Front Oncol. 2015 May 26;5:113. eCollection 2015. PubMed | Google Scholar

  10. Sacher A, Dahlberg S, Heng J, Mach S, Jänne P, Oxnard G. Lung cancer diagnosed in the young is associated with enrichment for targetable genomic alterations and poor prognosis. JAMA Oncol. 2016;2(3):313-20. PubMed | Google Scholar

  11. Yang S, Song Z, Cheng G. Genomic alterations and survival in young patients aged under 40 years with completely resected non-small cell lung cancer. Ann Transl Med. 2019;7(7):140. PubMed | Google Scholar

  12. Pan X, Lv T, Zhang F, Fan H, Liu H, Song Y. Frequent genomic alterations and better prognosis among young patients with non-small-cell lung cancer aged 40 years or younger. Clin Transl Oncol. 2018 Sep;20(9):1168-1174. Epub 2018 Feb 19. PubMed | Google Scholar

  13. Capewell S, Wathen CG, Sankaran R, Sudlow MF. Lung cancer in young patients. Respiratory Medecine. 1992;86(6):499-502. PubMed | Google Scholar

  14. McDuffie HH, Klaassen DJ, Dosman JA. Characteristics of patients with primary lung cancer diagnosed at age of 50 years or younger. Chest. 1989 Dec;96(6):1298-301. PubMed | Google Scholar

  15. Mirsadraee S, Oswal D, Alizadeh Y, Caulo A, van Beek E. The 7th lung cancer TNM classification and staging system: Review of the changes and implications. World J Radiol. 2012;4(4):128-34. PubMed | Google Scholar

  16. Funakoshi Y, Takeda S, Kadota Y, Kusu T, Maeda H. Clinical Characteristics and Surgery of Primary Lung Cancer in Younger Patients. Asian Cardiovasc Thorac Ann. 2008;16(5):387-91. PubMed | Google Scholar

  17. Cornere MM, Fergusson W, Kolbe J, Chistmas TI. Characteristics of patients with lung cancer under the age of 45 years: A case control study. Respiratory. 2001;6(4):293-6. PubMed | Google Scholar

  18. Minami H, Masahiro Y, Hidehito M, Sakamoto T, Tsubota N. Lung cancer treated surgically in patients < 50 years of age. Chest. 2001;120(1):32-6. PubMed | Google Scholar

  19. Tominaga K, Mori K, Yokoi K, Noda M, Goto N, Machida S et al. Lung cancer in patients under 50 years old. Jpn J Cancer Res. 1999;90(5):490-5. PubMed | Google Scholar

  20. Gadgeel SM, Ramalingam S, Cummings G, Kraut MJ, Wozniak AJ, Gaspar LE et al. Lung cancer in patients < 50 years of age: the experience of an academic multidisciplinary program. Chest. 1999;115(5):1232-6. PubMed | Google Scholar

  21. Green LS, Fortoul TI, Ponciano G, Robles C, Rivero O. Bronchogenic cancer in patients under 40 years old: the experience of a Latin American country. Chest. 1993;104(5):1477-81. PubMed | Google Scholar

  22. Skarin AT, herbst RS, Leong TL, Bailey A, Sugarbaker D. Lung cancer in patients under age 40. Lung cancer. 2001;32(3):255-64. PubMed | Google Scholar

  23. Lienert T, Serke M, Schoönfeld N, Loddenkemper R. Lung cancer in young females. Eur Respir J. 2000;16(5):986-90. PubMed | Google Scholar

  24. Awadh-Behbehani N, Al-Hmood K, Ayed A, Memon A, Ali A. Comparison between young and old patients with bronchogenic carcinoma. Acta Oncologica. 2000;39(8):995-9. PubMed | Google Scholar

  25. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®). Non-Small cell lung cancer. Version 1.2020 - November 6,2019. Accessed 20 November 2019.

  26. Jubelirer SJ, Wilsobn RA. Lung cancer in patients younger than 40 years of age. Cancer. 1991;67(5):1436-8. PubMed | Google Scholar

  27. Bourke W, Milstein D, Giura R, Donghi M, Luisetti M, Rubin AH et al. Lung cancer in young adults. Chest. 1992;102(6):1723-9. PubMed | Google Scholar

  28. Etzel CJ, Lu M, Merriman K, Liu M, Vaporciyan A, Spitz MR. An epidemiologic study of early onset lung cancer. Lung Cancer. 2006 May;52(2):129-34. Epub 2006 Mar 27. PubMed | Google Scholar

  29. Liu NS, Spitz MR, Kemp BL, Cooksley C, Fossella FV, Lee JS et al. Adenocarcinoma of the lung in young patients: the M D Anderson experience. Cancer. 2000;88(8):1837-41. PubMed | Google Scholar

  30. Salloum RG, Smith TJ, Jensen GA, Lafata JE. Survival among non-small cell lung cancer patients with poor performance status after first line chemotherapy. Lung Cancer. 2012 Sep;77(3):545-9. Epub 2012 May 26. PubMed | Google Scholar

  31. Chermiti Ben Abdallah F, Ben Ali G, Sadok Boudaya M, Mlika M, Chtourou A, Taktak S et al. Traitement et pronostic du cancer bronchique non à petites cellules au stade avancé. Rev Mal Respir. 2014 Mar;31(3):214-20. Epub 2013 Oct 8. PubMed | Google Scholar

  32. Ni XF, Wu P, Wu CP, Ji M, Wu J, Gu XF et al. Elevated serum C-reactive protein, carcinoembryonic antigen and N2 disease are poor prognostic indicators in non-small cell lung cancer. Asia Pac J Clin Oncol. 2015 Dec;11(4):e22-30. Epub 2014 May 30. PubMed | Google Scholar

  33. Iivanainen S, Ahvonen J, Knuuttila A, Tiainen S, Koivunen JP. Elevated CRP levels indicate poor progression free and overall survival on cancer patients treated with PD-1 inhibitors. ESMO Open. 2019 Aug 16;4(4):e000531. eCollection 2019. PubMed | Google Scholar

  34. Yang JR, Xu JY, Chen GC, Yu N, Yang J, Zeng DX et al. Post-diagnostic C-reactive protein and albumin predict survival in Chinese patients with non-small cell lung cancer: a prospective cohort study. Sci Rep. 2019;9(1):8143. PubMed | Google Scholar

  35. Xiao X, Wang S, Long G. C-reactive protein is a significant predictor of improved survival in patients with advanced non-small cell lung cancer. Medicine (Baltimore). 2019;98(26):e16238. PubMed | Google Scholar

  36. Jin Y, Sun Y, Shi X, Zhao J, Shi L, Yu X. Prognostic value of circulating C- reactive protein levels in patients with non-small cell lung cancer: a systematic review with meta-analysis. J Cancer Res Ther. 2014;10 Suppl:C160-6. PubMed | Google Scholar

  37. Tolia M, Tsoukalas N, Kyrgias G, Mosa E, Maras A, Kokakis I et al. Prognostic Significance of Serum Inflammatory Response Markers in Newly Diagnosed Non-Small Cell Lung Cancer before Chemoirradiation. Biomed Res Int. 2015;2015:485732. Epub 2015 Aug 3. PubMed | Google Scholar

  38. Khaksar E, Askarishahi M, Hekmatimoghaddam S, Vahedian-Ardakani H. Cox Regression and Parametric Models: Comparison of How They Determine Factors Influencing Survival of Patients with Non-Small Cell Lung Carcinoma. Asian Pac J Cancer Prev. 2017;18(12):3389-93. PubMed | Google Scholar